Shareprice
02 Nov 2024

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2024

Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in...
7 October, 2024 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer News Corporate Information Other Corporate Information English IR
Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision...
29 August, 2024 FluoGuide A/S publishes interim report for the period January – June 2024 News English Regulatory Listing Regulation Report Interim Q2 IR
Copenhagen, Denmark, 29 August 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
26 August, 2024 FluoGuide appoints Jens Ellrich as Chief Medical Officer News Corporate Action Other English Regulatory Listing Regulation IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...
18 June, 2024 FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million News Corporate Action Shares Issuance English Regulatory MAR IR
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...
18 June, 2024 FluoGuide intends to carry out a directed share issue of approximately SEK 60 million News Corporate Action Shares Issuance English Regulatory MAR IR
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...
30 May, 2024 FluoGuide A/S publishes interim report for the period January – March 2024 News English Regulatory Listing Regulation Report Interim Q1 IR
Copenhagen, Denmark, 30 May 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...
27 May, 2024 FluoGuide selects laser system for photothermal cancer therapy with FG001 News Corporate Information Other Corporate Information English IR
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...
20 March, 2024 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR
Copenhagen, Denmark, 20 March 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...

Calendar &
upcoming reports


29 August 2024

Q2 report 2024


27 November 2024

Q3 report 2024


27 February 2025

Annual report 2024

Show all posts